Coöperatie Koninklijke Avebe UA engages in the derivation of nutrition from potatoes. It offers potato starch and protein. The firms products are used in paper, construction materials, textiles, adhesives, and animal feed. The company was founded in 1919 and is headquartered in Veendam, the Netherlands.

Commonwealth Scientific & Industrial Research Organisation provides scientific and industrial research services. It plays a role in collaboration within the Australian national innovation system and as an advisor to government, industry and the community. The company was founded in 1916 and is headquartered in Canberra, Australia.

Regeneron Pharmaceuticals is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders. The company’s product portfolio includes EYLEA, an aflibercept injection; ARCALYST, a rilonacept Injection for subcutaneous use; ZALTRAP for metastatic colorectal cancer; trap fusion proteins; and fully human monoclonal antibodies. On March 26, 2012, it was announced that Sanofi and Regeneron are in development with a new cholesterol drug which will help reduce cholesterol up to 72%. Regeneron Pharmaceuticals was founded in 1988 and is currently headquartered in New York, USA.

Formed in 1985, the University of Maryland Biotechnology Institute (UMBI) is part of the University System of Maryland. It was created to provide a unified focus for Maryland's biotechnology research and education.

PBL develops innovative technologies from public and private sources worldwide - turning ideas into patented, scientifically validated and licensable technologies. PBL invests in building intellectual property protection, and develops technologies through proof-of-concept and prototype stage and licenses onwards to a wide variety of industry sectors. Our interests cover AgBiotech, Food / Nutrition, Microbiology, Biotechnology and related Life Science industries. We market our technologies internationally and have regular contact with a very wide range of industrial customers, licensees and development partners.

The Sainsbury Laboratory is a private company headquartered in Norwich, UK, that operates laboratories for research on science of plant-microbe interactions. The firm was founded in 1987.\nThe company says this about itself: The Sainsbury Laboratory is a world-leading research institute working on the science of plant-microbe interactions. The Laboratory has developed an enviable reputation for the quality of its fundamental scientific research but is also committed to delivering science solutions that reduce crop losses to important diseases. The Sainsbury Laboratory favours daring, long-term research and has state-of-the- art technologies and support services to enable cutting-edge science. The Laboratory provides an outstanding training environment that prepares postgraduate students, postdoctoral scientists and early career project leaders to excel in their careers. Many scientists who have passed through the Laboratory have continued their careers in prestigious laboratories and institutes around the world.

Suntory Holdings Ltd. operates as a holding company with interests in the production and distribution of alcoholic and non-alcoholic beverages, health, beauty, and processed food products. Its services include formulation and promotion of group wide management strategies and corporate functions; sale of alcoholic beverages such as whiskey, beer, and wine; soft drinks; and other beverages such as tea and canned coffee. The company was founded by Shinjiro Torii in 1899 and is headquartered in Osaka, Japan.

Immunex Corporation develops, manufactures, and markets therapeutic products for the treatment of cancer, infectious diseases, and autoimmune disorders. It offers products, such as Enbrel that is used in the treatment of rheumatoid arthritis; Novantrone, which is used to treat acute nonlymphocytic leukemia and pain associated with prostate cancer; and Leukine for use in bone marrow transplant patients. The company has franchise operations. It has a strategic alliance with American Home Products. The company was founded in 1981 and is based in Seattle, Washington. As of July 15, 2002, Immunex Corporation was acquired by Amgen, Inc.

Shanghai Rigen Biotechnology Co. Ltd. is a company headquartered in China. The firm provides research and development services.

Laboratoire Francais du Fractionnement et des Biotechnologies SA provides plasma-derived medicinal products. It undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The firm's products include albumin and immunoglobulin. It also offers products for rare pathologies. The company was founded in 1994 and is headquartered in Les Ulis, France.

Deltagen, Inc. provides drug discovery tools and services to the biopharmaceutical industry and to the academic research community in the United States. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was founded in 1997 and is headquartered in San Mateo, California.

Shenzhen Boao Kang Biotechnology Co., Ltd., established on 2013-11-04, Business scope includes general business items:Research on Biotechnology Products,Biological product,biotechnology products,Development of biochemical scientific research reagents and related technical services,Biochemical Research Instruments,Reagent,Sales of laboratory consumables;Operating Class II medical devices;Domestic Trade(Does not contain franchise,monopoly,Specially Controlled Commodities);Operating import and export business(law,Administrative regulations,Except for items prohibited by the State Council,Restricted projects must obtain a license before operating).,The licensing program is:

Temasek Life Sciences Laboratory (TLL) was established in August 2002 and as a Singapore Non Profit Philanthropic Research Organisation focusing primarily on understanding the cellular mechanisms that underlie the development and physiology of plants, fungi and animals which provides foundation for biotechnology innovation.

Alnylam is the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare genetic, cardio-metabolic, hepatic infectious, and central nervous system (CNS)/ocular diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach for the treatment of a wide range of severe and debilitating diseases.

Rijk Zwaan Zaadteelt en Zaadhandel BV develops and distributes vegetables and seeds. The company was founded in 1932 and is headquartered in de Lier, the Netherlands.

Shanghai Hengshi Biotechnology Co., Ltd., established on 2019-10-15, Business scope includes general items:engaged in biotechnology(human stem cells,Except for the development and application of genetic diagnosis and treatment technology)technology development in the field,Technical Services,technology transfer,technical consulting,marketing planning,Business Management Consulting,Business Consulting,Import and export,Technology Import and Export,Specialty Chemicals(Free of Hazardous Chemicals),Sales of bio-based materials,Research and development of bio-based materials technology,Research and development of bio-based material polymerization technology,Manufacturing of bio-based materials.(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

CEA is a French government-funded technological research organisation. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world. The CEA is the French Alternative Energies and Atomic Energy Commission (Commissariat à l'énergie atomique et aux énergies alternatives). It is a public body established in October 1945 by General de Gaulle. A leader in research, development and innovation, the CEA mission statement has two main objectives: To become the leading technological research organization in Europe and to ensure that the nuclear deterrent remains effective in the future. The CEA is active in four main areas: low-carbon energies, defense and security, information technologies and health technologies. In each of these fields, the CEA maintains a cross-disciplinary culture of engineers and researchers, building on the synergies between fundamental and technological research. The total CEA workforce consisted of 15 838 employees. Across the whole of the CEA (including both civilian and military research), there were 1556 PhD students and 293 post-docs. The CEA is based in ten research centers in France, each specializing in specific fields. The laboratories are located in the Paris region, the Rhône-Alpes, the Rhône valley, the Provence-Alpes-Côte d'Azur region, Aquitaine, Central France and Burgundy. The CEA benefits from the strong regional identities of these laboratories and the partnerships forged with other research centers, local authorities and universities.

Institut National de la Sant? et de la Recherche M?dicale provides medical services. The firm specializes in biomedical research and public health research. The company is headquartered in Paris, Cedex, France.